Join +750K new investors every month who copy stock picks from billionaire's portfoliosSign Up Free

BRIEF-Canopy Growth Corp, Bedrocan Canada launch Brazil joint venture

Published 2016-06-28, 06:46 a/m
© Reuters.  BRIEF-Canopy Growth Corp, Bedrocan Canada launch Brazil joint venture
WEED
-

June 28 (Reuters) - Canopy Growth Corp CGC.V
* Canopy Growth Corporation and Bedrocan Canada launch
Brazil joint venture
* Says closing of an agreement with Sao Paulo-based
Entourage Phytolab S.A. with wholly-owned subsidiary Bedrocan
Canada Inc
* Co will partner with Entourage to develop cannabis-based
pharmaceutical medical products for Brazilian, international
markets
* Says to create a new company called Bedrocan Brazil S.A
* Bedrocan Brazil will hold sole local rights to use
Bedrocan brand and genetic material and cultivation technology
of Bedrocan in Brazil
* Canopy Growth Corp says new company will facilitate
importation of bedrocan's proprietary standardized cannabis
varieties into Brazilian market
* Canopy Growth Corp says initially, Bedrocan Brazil will
import cannabis products into Brazil from Canada or Netherlands
* Will partner with entourage to develop cannabis-based
pharmaceutical medical products for Brazilian and international
markets
* Entourage will be responsible for developing standardized
cannabis extracts for pre-clinical and clinical trials
* Canopy Growth Corp says anticipated that product clinical
trials will begin in 2016 and be completed by end of 2017
* Canopy Growth Corp says targeting submission for market
approval by Anvisa, Brazilian health surveillance agency, by
2018
* Says initially, Bedrocan Brazil will import cannabis
products into Brazil from Canada or Netherlands

Source text for Eikon: ID:nCNWFhqZRa
Further company coverage: CGC.V

(Bengaluru Newsroom: +1 646 223 8780)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.